Product Code: 978-1-68038-237-2
Peripheral Vascular Devices Market Growth & Trends:
The global peripheral vascular devices market size is expected to reach USD 14.8 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth are the growing prevalence of peripheral arterial disease (pad), increasing clinical trials & studies, technological advancements, and government initiatives. Pharmaceutical companies and medical device manufacturers are increasingly funding clinical trials to explore innovative solutions for peripheral vascular disease PVD. This trend accelerates product development cycles and encourages collaboration between industry stakeholders and academic institutions.
As more studies are initiated, the data generated can significantly help improve these devices' performance and effectiveness. Moreover, regulatory support for increasing clinical trials is anticipated to boost these initiatives, thereby enhancing the development of advanced solutions in the market. For instance, in June 2024, AVS received an Investigational Device Exemption (IDE) from the FDA to conduct a clinical trial for its Pulsatile Intravascular Lithotripsy (PIL) system. The trial will assess the safety and effectiveness of the PIL system in patients with peripheral artery disease. AVS plans to initiate the study across multiple sites, marking a significant step forward in developing less invasive treatment options for patients suffering from calcified vascular conditions. Such efforts by market players, coupled with the developing R&D environment, are expected to drive market growth over the forecast period.
Moreover, the evolving competitive landscape of the peripheral vascular devices market is leading to several initiatives by market players that significantly increase their offerings and availability of these advanced devices to the healthcare sector globally, such as partnerships, expansion, agreements, acquisitions, and others. For instance, in June 2024, Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., specializing in innovative solutions for carotid artery disease. The acquisition, valued at approximately USD 1.1 billion, aims to enhance Boston Scientific's portfolio in vascular intervention and expand its presence in the growing carotid artery market. Such initiatives by the market players to increase their offers, coupled with the growing availability of these devices, are expected to drive market growth over the forecast period.
Peripheral Vascular Devices Market Report Highlights:
- Based on type, the peripheral stents segment held the largest share of nearly 21.7% in 2024. The rising government support in the form of funding and approvals is encouraging manufacturers to develop technologically advanced peripheral stents.
- Based on application, the peripheral arterial disease (PAD) segment held the largest share of nearly 45.3% in 2024. The rising prevalence of peripheral artery disease and government initiatives drive segment growth.
- Based on end-use, the hospitals segment held the largest share of nearly 64.4% in 2024. Hospitals are crucial in administering advanced medical procedures, including Percutaneous Transmural Arterial Bypass (PTAB).
- North America dominated the peripheral vascular devices with a share of 38.9% in 2024. The peripheral vascular devices market exhibits consistent growth owing to several factors, including the growing incidence of Peripheral Artery Disease (PAD), rising geriatric population, and rapid advancements in medical technology.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.2.3. End use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market outlook
- 2.2. Segment outlook
- 2.2.1. Type outlook
- 2.2.2. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Peripheral Vascular Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing prevalence of PAD
- 3.2.1.2. Increasing clinical trials and studies
- 3.2.1.3. Novel product launch
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of treatment and devices
- 3.2.2.2. Product recalls
- 3.3. Peripheral Vascular Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Peripheral Vascular Devices Market: Type Estimates & Trend Analysis
- 4.1. Peripheral Vascular Devices Market: Type Dashboard
- 4.2. Peripheral Vascular Devices Market: Type Movement Analysis
- 4.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. Peripheral Stents
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.1. Iliac Artery Stents
- 4.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.2. Femoral Artery Stents
- 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.3. Carotid Artery Stents
- 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.4. Renal Artery Stents
- 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.5. Other Peripheral Stents
- 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. PTA Balloons
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Catheters
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.1.1. Angiography Catheters
- 4.6.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.1.2. Guiding Catheters
- 4.6.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.1.3. IVUS/OCT Catheters
- 4.6.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Endovascular Aneurysm Repair Stent Grafts
- 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7.1.1. Thoracic Endovascular Aneurysm Stent Grafts
- 4.7.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7.1.2. Abdominal Endovascular Aneurysm Stent Grafts
- 4.7.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8. Plaque Modification Devices
- 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8.1.1. Atherectomy Devices
- 4.8.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8.1.2. Thrombectomy Devices
- 4.8.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9. Peripheral Accessories
- 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.1. Guidewires
- 4.9.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.1.2. Workhorse Guidewires
- 4.9.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.1.3. Specialty Guidewires
- 4.9.1.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.1.4. Extra Support Guidewires
- 4.9.1.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.1.5. Frontline Finesse Guidewires
- 4.9.1.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.2. Peripheral Vascular Closure Devices
- 4.9.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.3. Balloon Inflation Devices
- 4.9.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9.1.4. Introducer Sheaths
- 4.9.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.10. Inferior Vena Cava Filters
- 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.10.2. Permanent Filters
- 4.10.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.10.3. Retrievable Filters
- 4.10.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.11. Hemodynamic Flow Alteration Devices
- 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.11.2. Chronic Total Occlusion Devices
- 4.11.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.11.3. Embolic Protection Devices
- 4.11.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Peripheral Vascular Devices Market: Application Estimates & Trend Analysis
- 5.1. Peripheral Vascular Devices Market: Application Dashboard
- 5.2. Peripheral Vascular Devices Market: Application Movement Analysis
- 5.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Peripheral Arterial Disease (PAD)
- 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Aneurysms
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Venous Diseases
- 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Others
- 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Peripheral Vascular Devices Market: End Use Estimates & Trend Analysis
- 6.1. Peripheral Vascular Devices Market: End Use Dashboard
- 6.2. Peripheral Vascular Devices Market: End Use Movement Analysis
- 6.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Ambulatory Surgical Centers
- 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Peripheral Vascular Devices Market: Regional Estimates & Trend Analysis by Country, Type , Application, End use and Region
- 7.1. Regional Dashboard
- 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Regulatory framework/ reimbursement structure
- 7.3.4.3. Competitive scenario
- 7.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.7. Norway
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.9. Denmark
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Regulatory framework/ reimbursement structure
- 7.4.9.3. Competitive scenario
- 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework/ reimbursement structure
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. Mexico
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Argentina
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ reimbursement structure
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. Abbott
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Koninklijke Philips N.V.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Edward Lifesciences Corporation
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Medtronic
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Teleflex Incorporated
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Cook Group
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Cordis
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Boston Scientific Corporation
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. W. L. Gore & Associates, Inc.
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Biotronik
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. BD
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Product benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. Terumo Corporation
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. Product benchmarking
- 8.3.15.4. Strategic initiatives